wire

Researchers have been awarded funding from Cancer Research UK to create the world's first vaccine to prevent ovarian cancer.

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression. The results, announced at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in Copenhagen, followed promising phase 2 trial findings.

The first participants have been recruited in Oxford for a new multinational clinical trial that will investigate whether a novel treatment can help slow the progression of chronic kidney disease (CKD).

A landmark GRAM Project study of global antimicrobial resistance (AMR) burden over time forecasts a sharp rise in deaths, with 39 million lives lost between now and 2050. Resistance to antibiotics led to at least one million deaths each year since 1990, with increasing rates of drug-resistant infections expected to claim more than 39 million lives between now and 2050 without further policy action, according to a landmark study by the Global Research on Antimicrobial Resistance (GRAM) Project.

Our focus for the coming academic year and beyond will be on taking a student-led harm reduction approach to all'addictive behaviours, including drug use.

Our focus for the coming academic year and beyond will be on taking a student-led harm reduction approach to drug use.

A fingertip device that closely mimics the sensation of interacting with real objects, developed by a team led by UCL researchers, paves the way for applications in diagnosing loss of touch, video calls, robotic surgery and hazardous waste handling.

Imperial spinout Dosium is working with the NHS to roll out a clinical decision support tool that provides dosage guidance to increase patient safety.

Scientists are calling for the public to help save endangered Welsh bees by registering bee sightings, helping to protect precious pollinators in Wales.

Over the past decade, the number of NHS general practices in England has decreased by 20% with 15% fewer qualified fulltime equivalent (FTE) general practitioners (GPs) per 1,000 patients, finds a new analysis involving a UCL researcher.

Researchers have proposed a new classification system for angina patients, co-authoring a scientific consensus statement introducing new terminology for ischaemic heart disease, which is the leading cause of death in men and women worldwide.

A cancer drug that unlocks the anti-inflammatory power of the immune system could help to reduce the risk of future heart attacks, according to research part-funded by the British Heart Foundation.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer's disease in the UK, following decades of work supported by UCL research.

One in four patients in vegetative or minimally conscious state able to perform cognitive tasks, study finds Around one in four patients with severe brain injury who cannot move or speak - because the

There is a need for comprehensive data on the long-term effects of weight loss drugs such as semaglutide or tirzapatide, as well as strategies for maintaining a healthier weight once people stop using them, argues a multidisciplinary team led by researchers from UCL.

University of Manchester scientists are part joining three of eight new networks, combining different research specialisms, to tackle one of humanity's biggest threats, antimicrobial resistance (AMR).

A new study highlights the need for government support for large-scale badger vaccination to eradicate bovine tuberculosis. The study, published today in People and Nature , reports on the results of a four-year pilot badger vaccination programme co-managed between farmers, scientists, and conservationists.

Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer's disease.

A dream come truefor parents Rosemary and Darren whose daughter Nessa born during the UNITY trial participation.

A new tool from Imperial and Molecular Dimensions could help biologists rapidly uncover valuable insights into the proteins found in cell membranes. Imperial is working with the company to commercialise a high-throughput test that will help scientists to acquire fundamental knowledge about integral membrane proteins - components of living cells that are the targets for 60% of prescribed drugs.

A new four-year research programme will address poor access to quality primary healthcare for patients with COPD - South America's fourth leading cause of death Health experts from the University of Birmingham are launching a project that will help to identify and treat patients with Chronic Obstructive Pulmonary Disease (COPD) across South America.

Dramatically improve outcomes for thousands of people in the UK affected by stroke each year.

A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCL, UCLH and the Francis Crick Institute.

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on ground-breaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.

Work will begin soon on a new hospital that will transform how we diagnose and treat cancer. Cambridge Cancer Research Hospital will treat patients across the East of England, but the research that takes place there promises to change the lives of cancer patients across the UK and beyond.

The Fleming Initiative is calling for designs for its inaugural Centre at St Mary's Hospital.

A new fast test may help identify children missing immunity to tetanus and other essential vaccines.

A new artificial intelligence (AI) system that could significantly reduce the time and cost required to recruit clinical trial patients for an advanced form of age-related vision loss has been developed by a team led by UCL and Moorfields Eye Hospital researchers. The system focuses on Geographic Atrophy (GA), an advanced form of dry age-related macular degeneration (AMD) leading to irreversible vision loss and legal blindness.

New data analysis highlights potential "serious consequences" for patient health and lengthy complaint processing times.

The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%.

Scientists at the University of Cambridge have discovered that a type of white blood cell - called a regulatory T cell - exists as a single large population of cells that constantly move throughout the body looking for, and repairing, damaged tissue. It's difficult to think of a disease, injury or infection that doesn't involve some kind of immune response, and our finding really changes the way we could control this response.

The University of Glasgow, alongside NHS Greater Glasgow & Clyde, has opened the PRIMUS-006 pancreatic cancer study, part of the Precision-Panc Platform.

Few people in the UK with early-stage Alzheimer's disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds a new study co-led by UCL researchers.

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at UCL and Great Ormond Street Hospital (GOSH).

A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at UCL and Great Ormond Street Hospital (GOSH).

Researchers from the University of Oxford will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Ministry of Health (MoH)-Rwanda and the Rwanda Biomedical Centre (RBC).

An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

The Southampton Clinical Trials Unit, based at the University of Southampton, has been chosen to run a new programme accelerating research into potentially ground-breaking cancer treatments.